Literature DB >> 22361661

Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.

Claudia Garnero1, Virginia Aiassa, Marcela Longhi.   

Abstract

A complex of sulfamethoxazole (SMX) and hydroxypropyl-β-cyclodextrin (HP-β-CD) was developed and characterized in order to investigate their interactions in aqueous solution and the solid state. The SMX solubility was significantly increased upon complexation with HP-β-CD, with the solubility isotherm being an A(N) type due to the presence of aggregates and the stability constant calculated for a 1:1 complex being 302 ± 3 M⁻¹. Fourier-transform infrared (FT-IR) spectroscopy and scanning electron microscopy (SEM) experiments were used to compare the freeze-dried system with a physical mixture, and demonstrated the complex formation in the solid state. The differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) showed that the thermal stability of SMX was enhanced in the presence of HP-β-CD. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22361661     DOI: 10.1016/j.jpba.2012.01.011

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Binding of sulfamethazine to β-cyclodextrin and methyl-β-cyclodextrin.

Authors:  Ariana Zoppi; Alicia Delrivo; Virginia Aiassa; Marcela Raquel Longhi
Journal:  AAPS PharmSciTech       Date:  2013-04-19       Impact factor: 3.246

2.  Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.

Authors:  Masoomeh Poorghorban; Umashankar Das; Osama Alaidi; Jackson M Chitanda; Deborah Michel; Jonathan Dimmock; Ronald Verrall; Pawel Grochulski; Ildiko Badea
Journal:  Int J Nanomedicine       Date:  2015-01-12

Review 3.  Alpinetin: A Review of Its Pharmacology and Pharmacokinetics.

Authors:  Ge Zhao; Yue Tong; Fei Luan; Wenjing Zhu; Chenglin Zhan; Tiantian Qin; Weixiao An; Nan Zeng
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.